Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Extracorporeal or ex vivo removal of antibodies or immune...
Patent
1995-06-07
1997-09-09
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Extracorporeal or ex vivo removal of antibodies or immune...
4241601, 435974, A61K 3921
Patent
active
056653557
ABSTRACT:
The invention provides assays for the presence or absence of CD4+ T cell subpopulations carrying particular V.beta. components of the T cell receptor (TCR-V.beta.) in persons infected with HIV, including amplification of mRNA from T cells with primers specific to each TCR-V.beta. to detect the presence or absence of each TCR-V.beta. in a sample and primers for use in such amplification assays are disclosed. The invention also provides assays of antibody-containing fluids of a person infected with HIV to determine the immunodeficiency where the fluid is suspected to contain an antibody having a paratope specific to an epitope on a TCR-V.beta.. The invention also provides a binding agent specific to a paratope where the paratope is specific to an epitope on a TCR-V.beta.. The invention also provides a method of assay of the fluids of a person infected with HIV to determine the immunodeficiency of the person which utilizes a binding agent specific to complexes containing anti-TCR-V.beta. antibody bound to TCR-V.beta.. The invention also provides a method of treatment of a person infected with HIV to attenuate or avert immunodeficiency which utilize a binding agent that is homologous with an epitope on TCR-V.beta.. The invention also provides a method of treatment of a person infected with HIV to attenuate or avert immunodeficiency which involves removing an antibody capable of binding to an epitope on TCR-V.beta. from the blood of a person infected with HIV. Finally, the invention provides a method of vaccination of a person infected or at risk for infection with HIV which raises antiidiotypic antibodies specific to free antibodies containing a paratope specific to an epitope on a TCR-V.beta..
REFERENCES:
patent: 4886743 (1989-12-01), Hood et al.
Acha-Orbea et al., Nature 350:207-211 (1991).
Bahadoran et al., Eur. J. Immun. 23(8):2041-2044 (1993).
Boldt-Houle et al., J. Leuk. Biol. 54(5):486-491 (1993).
Boyer et al., Clin. Exp. Immun. 92(3):437-441 (1993).
Brinchmann et al., J. of Vir. 66(10):5924-5928 (1992).
Chase "Researchers Offer New Theories To Unravel Mysteries of AIDS," The Wall Street Journal, Aug. 4, 1992.
Choi et al., Nature 350:203-207 (1991).
Dadaglio et al., Int. Conf. AIDS 9(1):203 (1993).
Davis et al., "Antibody and HIV-1 gp120 Recognition of CD4 Undermines the Concept of Mimicry Between Antibodies and Receptors," Nature 358:76-79(1992).
Deusch et al., "Biased T Cell Receptor V.beta. Repertoire of Peripheral Blood Derived and Intestinal CD+ T Cells in HIV Disease," Article No. ThA 1539, p. Th72, vol. 1, VIII International Conference on AIDS/III STD World Conference, Amsterdam, the Netherlands. 19-24 Jul. 1992.
Dwyer et al., 55th Meeting Am. Cell. Rheum. Arth. 34(Suppl.):S38 (1991).
Gorochov et al., "Conservation of the TCR-V-Beta Chains Repertoire in CD4+ T Cells During Progression of HIV Infection," Article No. ThA 1541, p. Th72, vol. 1, VIII International Conference on AIDS/III STD World Congress Amsterdam, The Netherlands. 19-24 Jul. 1992.
Hodars et al., "T Cell Receptor V Gene Expression on CD4 and CD8 Peripheral T Cells From HIV Patients," Article No. ThA 1540, p. Th72, vol. 1, VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands. 19-24 Jul. 1992.
Hugin et al., "A Virus-Encoded `Superantigen` in a Retrovirus-Induced Immunodeficiency Syndrome of Mice," Science 252:424-427 (1991).
Imberti et al., "European Biotechnology Today," Malarasi et al., ed. pp. 267-273 (1992).
Imberti et al., Science 254:860-862 (1991).
Kion et al., "Anti-HIV and Anti-Anti-MHC Antibodies in Alloimmune and Autoimmune Mice," Science 253:1138-1140 (1991).
Laurence et al., Nature 358:255-259 (1992).
Laurence et al., "HIV-1 Acts As A Superantigen: TCR V.beta. Expression Regulates HIV Replication," Article No. ThA 1538, p. Th72, vol. 1, VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands. 19-24 Jul. 1992.
Marx, "Autoimmunity Explored in AIDS Pathology," Science 254:799 (1991).
Marx, "Clue Found to T Cell Loss in AIDS," Science 254:798-800 (1991).
Moretta et al., "Superantigens in HIV Infection: Expansion or Deletion of T Cell Subsets Expressing Certain V.beta.s," Orbetello (GR), 13-17 Jun. 1992.
Newell et al., "Death of Mature T Cells by Separate Ligation of CD4 and the T Cell Receptor for Antigen," Nature 347:286-289 (1990).
Pantaleo et al., Int. Conf. AIDS, Article No. ThA 1536 p. Th71 (1992).
Posnett et al., AIDS 7(5):625-31 (1993).
Soudeyns et al., Sem. Immunol. 5(3):175-185 (1993).
Stevenson et al., J. Vir. 61(12):3741-3748 (1987).
Tunnacliffe et al., PNAS 82:5068-5072 (1985).
Van Brunt, "T Cell Files To Sell CD4 Test," BioWorld Today, p. 2, Oct. 22, 1992.
Van Dongen et al., Clin. Chim. Acta. 198:1-92 (1991).
Wilson et al., "Positive Selection of the V.beta. 5 TCR Gene Product in HIV Infected Individuals," Article No. ThA 1537, p. Th72, vol. 1, VIII International Conference on AIDS/III STD World Congress, Amsterdam, The Netherlands. 19-24 Jul. 1992.
Minneapolis Star Tribune, "Key Immune Cell May Slow Aids," Jul. 23, 1992.
Consorzio per le Biotecnologie
Nucker Christine M.
Stucker Jeffrey
LandOfFree
Diagnosis and treatment of AIDS onset does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnosis and treatment of AIDS onset, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnosis and treatment of AIDS onset will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-67583